Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Biobehavioral Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Status: Enrolling
Updated:  4/3/2018
Wayne State University
mi
from
Detroit, MI
Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Biobehavioral Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Status: Enrolling
Updated: 4/3/2018
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Catalina Research Institute
mi
from
Chino, CA
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
University of California, San Diego
mi
from
San Diego, CA
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Rocky Mountain Research
mi
from
Wheat Ridge, CO
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Rocky Mountain Research
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Northwestern University
mi
from
Chicago, IL
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Indiana University
mi
from
Indianapolis, IN
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Sterling Research Ltd
mi
from
Cincinnati, OH
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Sterling Research Ltd
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Premier Clinical Research
mi
from
Clarksville, TN
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Premier Clinical Research
mi
from
Clarksville, TN
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Virginia Commonwealth University
mi
from
Richmond, VA
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
GI Specialists of Georgia
mi
from
Marietta, GA
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
GI Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Gastro One
mi
from
Germantown, TN
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
Quality Medical Research Pllc
mi
from
Nashville, TN
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
Quality Medical Research Pllc
mi
from
Nashville, TN
Click here to add this to my saved trials
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated:  4/3/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients
Status: Enrolling
Updated: 4/3/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Hialeah
mi
from
Hialeah, FL
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Hialeah
mi
from
Hialeah, FL
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Lake Worth
mi
from
Lake Worth, FL
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Lake Worth
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Lauderdale Lakes
mi
from
Lauderdale Lakes, FL
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Lauderdale Lakes
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Miami
mi
from
Miami, FL
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Greenville
mi
from
Greenville, SC
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated:  4/3/2018
Investigator Site - Arlington
mi
from
Arlington, TX
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Status: Enrolling
Updated: 4/3/2018
Investigator Site - Arlington
mi
from
Arlington, TX
Click here to add this to my saved trials
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
Status: Enrolling
Updated:  4/3/2018
Creighton University
mi
from
Omaha, NE
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
Status: Enrolling
Updated: 4/3/2018
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Status: Enrolling
Updated:  4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Status: Enrolling
Updated: 4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pioglitazone to Treat Opioid Withdrawal Symptoms
Pioglitazone as an Aid During Buprenorphine Taper
Status: Enrolling
Updated:  4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Pioglitazone to Treat Opioid Withdrawal Symptoms
Pioglitazone as an Aid During Buprenorphine Taper
Status: Enrolling
Updated: 4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated:  4/4/2018
The Mayo Clinic
mi
from
Rochester, MN
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated: 4/4/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated:  4/4/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated: 4/4/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated:  4/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Hyperbaric Oxygen for Ulcerative Colitis
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
Status: Enrolling
Updated: 4/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
University of Alabama
mi
from
Birmingham, AL
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
Massachusetts General Hospital (MGH)
mi
from
Boston, MA
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
Massachusetts General Hospital (MGH)
mi
from
Boston, MA
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
University of New Mexico
mi
from
Albuquerque, NM
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
University of North Carolina
mi
from
Raleigh, NC
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
University of North Carolina
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
The Christ Hospital
mi
from
Cincinnati, OH
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
University of Oklahoma
mi
from
Oklahoma City, OK
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
Brown University (WIHRI)
mi
from
Providence, RI
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
Brown University (WIHRI)
mi
from
Providence, RI
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
Providence Sacred Heart
mi
from
Spokane, WA
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
Providence Sacred Heart
mi
from
Spokane, WA
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
University of Wisconsin
mi
from
Madison, WI
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated:  4/4/2018
Houston Methodist
mi
from
Houston, TX
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women
Status: Enrolling
Updated: 4/4/2018
Houston Methodist
mi
from
Houston, TX
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Endoscopic Research, Inc.
mi
from
Orlando, FL
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Endoscopic Research, Inc.
mi
from
Orlando, FL
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Rush University Medical Center
mi
from
Chicago, IL
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
New Orleans Research Institute
mi
from
Metairie, LA
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
New Orleans Research Institute
mi
from
Metairie, LA
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Louisiana Research Center, LLC
mi
from
Shreveport, LA
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Louisiana Research Center, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Commonwealth Clinical Studies
mi
from
Brockton, MA
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Commonwealth Clinical Studies
mi
from
Brockton, MA
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Cumberland Research Associates
mi
from
Fayetteville, NC
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Cumberland Research Associates
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Main Line Gastroenterology Associates
mi
from
Malvern, PA
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Main Line Gastroenterology Associates
mi
from
Malvern, PA
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Radiant Research, Inc.
mi
from
Anderson, SC
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated:  4/4/2018
Gastro One
mi
from
Germantown, TN
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Status: Enrolling
Updated: 4/4/2018
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials